What does Revolution Medicines, Inc. do?

Jun 22 2025 06:52 PM IST
share
Share Via
Revolution Medicines, Inc. is a clinical-stage precision oncology company developing targeted therapies in the pharmaceuticals and biotechnology sector. As of March 2025, it has a market cap of approximately $7.29 billion and reported a net profit loss of $213 million.
Overview:
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing targeted therapies within the pharmaceuticals and biotechnology industry. Financial Snapshot: Net Profit: -213 Million (Quarterly Results - Mar 2025) Market cap: USD 7,290.51 Million (Small Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.01 Return on Equity: -33.70% Price to Book: 3.51 Contact Details: Address: 700 Saginaw Dr, REDWOOD CITY CA: 94063-4752 Tel: 1 415 7663638 Fax: 1 302 6365454 Website: http://revolutionmedicines.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News